Capricor Therapeutics, Inc.

NasdaqCM:CAPR 株式レポート

時価総額:US$154.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Capricor Therapeutics マネジメント

マネジメント 基準チェック /44

Capricor Therapeutics'の CEO はLinda Marbánで、 Jan2010年に任命され、 の在任期間は 14.42年です。 の年間総報酬は$ 747.32Kで、 29.5%給与と70.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.62%を直接所有しており、その価値は$ 989.64K 。経営陣と取締役会の平均在任期間はそれぞれ12.3年と10.6年です。

主要情報

Linda Marbán

最高経営責任者

US$747.3k

報酬総額

CEO給与比率29.5%
CEO在任期間14.5yrs
CEOの所有権0.6%
経営陣の平均在職期間12.3yrs
取締役会の平均在任期間10.7yrs

経営陣の近況

Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

May 08
Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

Recent updates

Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

May 08
Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet

Apr 19
Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet

We're Not Very Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Rate

Apr 16
We're Not Very Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Rate

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 03
Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?

Dec 13
Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation

A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)

Nov 03
A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)

Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03

Aug 10

Companies Like Capricor Therapeutics (NASDAQ:CAPR) Are In A Position To Invest In Growth

Feb 01
Companies Like Capricor Therapeutics (NASDAQ:CAPR) Are In A Position To Invest In Growth

We Think Capricor Therapeutics (NASDAQ:CAPR) Can Afford To Drive Business Growth

Oct 14
We Think Capricor Therapeutics (NASDAQ:CAPR) Can Afford To Drive Business Growth

Capricor Therapeutics Announces Another 'Final' 12-Month P2 Duchenne Muscular Dystrophy Trial Result

Sep 25

Capricor Therapeutics slumps 9% on $75M stock offering

Jun 21

Capricor Therapeutics (NASDAQ:CAPR) Is In A Good Position To Deliver On Growth Plans

May 16
Capricor Therapeutics (NASDAQ:CAPR) Is In A Good Position To Deliver On Growth Plans

When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Turn A Profit?

Mar 13
When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Turn A Profit?

Capricor signs intellectual property license for COVID-19 serology test platform

Feb 01

Capricor and Lonza tie up in DMD development

Jan 12

CEO報酬分析

Capricor Therapeutics の収益と比較して、Linda Marbán の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$747kUS$221k

-US$22m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$1mUS$210k

-US$29m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$23m

Dec 31 2021US$2mUS$200k

-US$20m

Sep 30 2021n/an/a

-US$18m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$17m

Dec 31 2020US$2mUS$150k

-US$14m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$229kUS$157k

-US$8m

Sep 30 2019n/an/a

-US$9m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$377kUS$233k

-US$15m

Sep 30 2018n/an/a

US$374k

Jun 30 2018n/an/a

US$2m

Mar 31 2018n/an/a

US$2m

Dec 31 2017US$602kUS$233k

US$2m

報酬と市場: Lindaの 総報酬 ($USD 747.32K ) は、 US市場 ($USD 1.66M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Lindaの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Linda Marbán (61 yo)

14.5yrs

在職期間

US$747,315

報酬

Dr. Linda Marbán, Ph.D. Co-founded Capricor Therapeutics, Inc. (also known as Capricor, Inc). in 2005 and also has been its Chief Executive Officer since 2010 and serves as its President. Dr. Marbán has be...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Frank Litvack
Executive Chairman of the Board12.5yrsUS$759.55k0.42%
$ 643.7k
Linda Marbán
Co-Founder14.5yrsUS$747.32k0.62%
$ 963.7k
Anthony Bergmann
CFO & Corporate Treasurer6.5yrsUS$730.85k0.0075%
$ 11.5k
Karen Krasney
Executive VP12.3yrsUS$740.77k0.063%
$ 96.8k
Kristi A. Elliott
Chief Science Officerno dataデータなしデータなし
Catherine Kelleher
Consultantno dataデータなしデータなし

12.3yrs

平均在職期間

64.5yo

平均年齢

経験豊富な経営陣: CAPRの経営陣は経験豊富で経験豊富です(平均在職期間は12.3年)。


取締役

名称ポジション在職期間報酬所有権
Frank Litvack
Executive Chairman of the Board12.5yrsUS$759.55k0.42%
$ 643.7k
Linda Marbán
Co-Founder10.7yrsUS$747.32k0.62%
$ 963.7k
George Dunbar
Independent Director10.7yrsUS$211.13k0.033%
$ 51.0k
Earl Collier
Independent Director10.7yrsUS$222.37k0.18%
$ 274.6k
David Musket
Independent Director10.7yrsUS$237.36k0.17%
$ 264.6k
Francesco Muntoni
Member of Scientific Advisory Boardno dataデータなしデータなし
Pat Furlong
Member of Scientific Advisory Boardno dataデータなしデータなし
Eugenio Mercuri
Member of Scientific Advisory Boardno dataデータなしデータなし
Craig McDonald
Member of Scientific Advisory Boardno dataデータなしデータなし
Oscar Mayer
Member of Scientific Advisory Boardno dataデータなしデータなし
Michelle Eagle
Member of Scientific Advisory Boardno dataデータなしデータなし
Michael Taylor
Member of Scientific Advisory Board6.5yrsデータなしデータなし

10.7yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: CAPRの 取締役会 は経験豊富で 経験豊富 です ( 10.6年の平均在任期間)。